Vanda Pharmaceuticals (VNDA) Gains from Investment Securities (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Gains from Investment Securities of -$280000.0 in Q1 2026, down 105.39% quarter-over-quarter from $5.2 million in Q4 2025, and down 130.6% year-over-year from $915000.0 in Q1 2025.
Vanda Pharmaceuticals' Gains from Investment Securities history runs 17 years deep, the most recent figure standing at -$280000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 130.6% year-over-year to -$280000.0; the TTM figure through Mar 2026 stood at -$280000.0 (down 116.36% YoY), while the FY2025 annual figure was $915000.0, up 490.32% from the prior year.
- Gains from Investment Securities came in at -$280000.0 for Q1 2026 at Vanda Pharmaceuticals, down from $5.2 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $5.2 million in Q4 2025 to a low of -$5.2 million in Q3 2025.
- A 5-year average of -$111066.7 and a median of -$552000.0 in 2022 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities jumped 3249.68% in 2025 and tumbled 130.6% in 2026, its largest moves.
- Vanda Pharmaceuticals' Gains from Investment Securities stood at -$844000.0 in 2022, then surged by 428.44% to $2.8 million in 2023, then plunged by 94.41% to $155000.0 in 2024, then surged by 3249.68% to $5.2 million in 2025, then sank by 105.39% to -$280000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered -$280000.0, $5.2 million, and -$5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -280,000.00 |
| Mar 31, 2026 | -280,000.00 |
| Dec 31, 2025 | 5.19 Mn |
| Dec 31, 2025 | 5.19 Mn |
| Sep 30, 2025 | -5.19 Mn |
| Sep 30, 2025 | -5.19 Mn |
| Mar 31, 2025 | 915,000.00 |
| Mar 31, 2025 | 915,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Jun 30, 2024 | 641,000.00 |
| Jun 30, 2024 | 641,000.00 |
| Mar 31, 2024 | -641,000.00 |
| Mar 31, 2024 | -641,000.00 |
| Dec 31, 2023 | 2.77 Mn |
| Dec 31, 2023 | 2.77 Mn |
| Sep 30, 2023 | -928,000.00 |
| Sep 30, 2023 | -928,000.00 |
| Jun 30, 2023 | -735,000.00 |
| Jun 30, 2023 | -735,000.00 |
| Mar 31, 2023 | -1.11 Mn |
| Mar 31, 2023 | -1.11 Mn |
| Dec 31, 2022 | -844,000.00 |
| Dec 31, 2022 | -844,000.00 |
| Sep 30, 2022 | -637,000.00 |
| Sep 30, 2022 | -637,000.00 |
| Jun 30, 2022 | -423,000.00 |
| Jun 30, 2022 | -423,000.00 |
| Mar 31, 2022 | -552,000.00 |
| Mar 31, 2022 | -552,000.00 |
| Dec 31, 2021 | -506,000.00 |
| Dec 31, 2021 | -506,000.00 |
| Sep 30, 2021 | -556,000.00 |
| Sep 30, 2021 | -556,000.00 |
| Jun 30, 2021 | -371,000.00 |
| Jun 30, 2021 | -371,000.00 |
| Mar 31, 2021 | -295,000.00 |
| Mar 31, 2021 | -295,000.00 |
| Dec 31, 2020 | -397,000.00 |
| Dec 31, 2020 | -397,000.00 |
| Sep 30, 2020 | -666,000.00 |
| Sep 30, 2020 | -666,000.00 |
| Jun 30, 2020 | -381,000.00 |
| Jun 30, 2020 | -381,000.00 |
| Mar 31, 2020 | -314,000.00 |
| Mar 31, 2020 | -314,000.00 |
| Dec 31, 2019 | -268,000.00 |
| Dec 31, 2019 | -268,000.00 |
| Sep 30, 2019 | -777,000.00 |
| Sep 30, 2019 | -777,000.00 |
| Jun 30, 2019 | -423,000.00 |
| Jun 30, 2019 | -423,000.00 |
| Mar 31, 2019 | -317,000.00 |
| Mar 31, 2019 | -317,000.00 |
| Dec 31, 2018 | -14,000.00 |
| Dec 31, 2018 | -14,000.00 |
| Sep 30, 2018 | -40,000.00 |
| Sep 30, 2018 | -40,000.00 |
| Jun 30, 2018 | -226,000.00 |
| Jun 30, 2018 | -226,000.00 |
| Mar 31, 2018 | 5,298.00 |
| Mar 31, 2018 | 5,298.00 |
| Dec 31, 2017 | -188,000.00 |
| Dec 31, 2017 | -188,000.00 |
| Sep 30, 2017 | 643,000.00 |
| Sep 30, 2017 | 643,000.00 |
| Jun 30, 2017 | 242.43 Mn |
| Jun 30, 2017 | 242.43 Mn |
| Mar 31, 2017 | -133,000.00 |
| Mar 31, 2017 | -133,000.00 |
| Dec 31, 2016 | -59,000.00 |
| Dec 31, 2016 | -59,000.00 |
| Sep 30, 2016 | 632,242.00 |
| Sep 30, 2016 | 632,242.00 |
| Jun 30, 2016 | 1.89 Mn |
| Jun 30, 2016 | 1.89 Mn |
| Mar 31, 2016 | -12,000.00 |
| Mar 31, 2016 | -12,000.00 |
| Dec 31, 2015 | 176,000.00 |
| Dec 31, 2015 | 176,000.00 |
| Sep 30, 2015 | 1.56 Mn |
| Sep 30, 2015 | 1.56 Mn |
| Jun 30, 2015 | 166,606.00 |
| Jun 30, 2015 | 166,606.00 |
| Mar 31, 2015 | 188,000.00 |
| Mar 31, 2015 | 188,000.00 |
| Dec 31, 2014 | -675,000.00 |
| Dec 31, 2014 | -675,000.00 |
| Sep 30, 2014 | 32,386.00 |
| Sep 30, 2014 | 32,386.00 |
| Jun 30, 2014 | 32,386.00 |
| Jun 30, 2014 | 32,386.00 |
| Mar 31, 2014 | 436,000.00 |
| Mar 31, 2014 | 436,000.00 |
| Dec 31, 2013 | -300,000.00 |
| Dec 31, 2013 | -300,000.00 |
| Sep 30, 2013 | 49,520.00 |
| Sep 30, 2013 | 49,520.00 |
| Jun 30, 2013 | 151,250.00 |
| Jun 30, 2013 | 151,250.00 |
| Mar 31, 2013 | 2.56 Mn |
| Mar 31, 2013 | 2.56 Mn |
| Dec 31, 2012 | 672,145.00 |
| Dec 31, 2012 | 672,145.00 |
| Dec 31, 2011 | 4.25 Mn |
| Dec 31, 2011 | 4.25 Mn |
| Dec 31, 2010 | 680,754.00 |
| Dec 31, 2010 | 680,754.00 |